Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
about
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy.Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-AnalysisThe effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.The heritage of glatiramer acetate and its use in multiple sclerosis
P2860
Q30869048-3CB19939-ACDD-49BB-986A-726AA8D7749EQ34090086-03D99866-2477-4CB3-802B-DAAFFD0B9B34Q35959784-DD02F0C9-F394-472F-BB5E-59475540F5EBQ36211674-06EE0F84-1D54-4609-9B8A-5BF8820BA45AQ37003127-7014F63A-0E4F-4A9A-932A-5EB61F41156CQ38152977-338EF48A-C715-4DB8-9EAB-D2F722576F71Q38449394-F86649D1-E31E-4016-80A8-18732F54972AQ39037892-AE900B18-5EF1-454F-92B8-CBBB40A432DBQ39544816-7C626941-A341-488D-993D-5133A1A8A2B5Q56804781-F12040DB-B286-4868-B08C-F10B8959F80A
P2860
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
@en
type
label
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
@en
prefLabel
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
@en
P2093
P2860
P1433
P1476
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
@en
P2093
Douglas L Arnold
Samson Antel
Sridar Narayanan
P2860
P2888
P304
P356
10.1007/S00415-013-6903-5
P577
2013-04-16T00:00:00Z